In summary, DDX23 knockdown could significantly suppress the malignant phenotypes of pancreatic cancer cells, in vivo tumor growth as well as lung metastasis in synergy with GEM treatment potentially by regulating PI3K/Akt signaling. The gene discussed is DDX23; the disease is familial pancreatic carcinoma.